Group One Trading’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-3,355
| Closed | -$771 | – | 3800 |
|
2024
Q4 | $771 | Sell |
3,355
-4,279
| -56% | -$983 | ﹤0.01% | 1844 |
|
2024
Q3 | $16.4K | Buy |
7,634
+1,234
| +19% | +$2.65K | ﹤0.01% | 1200 |
|
2024
Q2 | $33K | Buy |
+6,400
| New | +$33K | ﹤0.01% | 1077 |
|
2024
Q1 | – | Sell |
-1,279
| Closed | -$9.96K | – | 3400 |
|
2023
Q4 | $9.96K | Hold |
1,279
| – | – | ﹤0.01% | 1407 |
|
2023
Q3 | $5.05K | Hold |
1,279
| – | – | ﹤0.01% | 1513 |
|
2023
Q2 | $4.03K | Hold |
1,279
| – | – | ﹤0.01% | 1429 |
|
2023
Q1 | $3.42K | Sell |
1,279
-97
| -7% | -$259 | ﹤0.01% | 1496 |
|
2022
Q4 | $4.94K | Buy |
1,376
+310
| +29% | +$1.11K | ﹤0.01% | 1558 |
|
2022
Q3 | $7K | Buy |
+1,066
| New | +$7K | ﹤0.01% | 1655 |
|
2022
Q2 | – | Sell |
-1,423
| Closed | -$17K | – | 3433 |
|
2022
Q1 | $17K | Buy |
+1,423
| New | +$17K | ﹤0.01% | 1672 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 3438 |
|
2021
Q3 | – | Sell |
-2,335
| Closed | -$127K | – | 3348 |
|
2021
Q2 | $127K | Buy |
+2,335
| New | +$127K | ﹤0.01% | 1258 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 3009 |
|
2020
Q4 | – | Sell |
-600
| Closed | -$53K | – | 2724 |
|
2020
Q3 | $53K | Buy |
600
+580
| +2,900% | +$51.2K | ﹤0.01% | 1066 |
|
2020
Q2 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 1301 |
|
2020
Q1 | – | Sell |
-13
| Closed | -$1K | – | 2280 |
|
2019
Q4 | $1K | Buy |
13
+10
| +333% | +$769 | ﹤0.01% | 1281 |
|
2019
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 2255 |
|
2019
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 2179 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 2129 |
|
2018
Q4 | – | Sell |
-32
| Closed | -$4K | – | 2161 |
|
2018
Q3 | $4K | Sell |
32
-292
| -90% | -$36.5K | ﹤0.01% | 1272 |
|
2018
Q2 | $33K | Buy |
324
+4
| +1% | +$407 | ﹤0.01% | 991 |
|
2018
Q1 | $41K | Sell |
320
-510
| -61% | -$65.3K | ﹤0.01% | 919 |
|
2017
Q4 | $81K | Buy |
+830
| New | +$81K | ﹤0.01% | 844 |
|